Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | trouble causé par un médicament | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Drug | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | complication | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Drug, medicament or biological substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | reazione avversa causata da sostanza | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | true | Inferred relationship | Some | 1 | |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | Adverse reaction (disorder) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Adverse reaction caused by over the counter drug | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Analgesics and nonsteroidal anti-inflammatory drug adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Diagnostic agent adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups primarily affecting gastrointestinal system adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anesthetics and medical gases adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antineoplastic/immunosuppressant/immunostim adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups primarily affecting central nervous system adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups primarily affecting autonomic nervous system adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups primarily affecting respiratory system adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups and agents primarily acting on skin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups primarily affecting musculoskeletal system adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups primarily used obs, gyn.+ urinary tract dis adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Chelating agents and antidotes adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Alternative medicines adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Miscellaneous fluids and solutions adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
effet indésirable aux préparations topiques diverses | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to bases and inactive substances | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anti-infectives adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Vaccine, immunoglobulins and antisera adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Hormone, synthetic hormone substitute or hormone antagonist adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Hematological agents adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Foods, vitamins, electrolytes inorganic salts adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups primarily affecting cardiovascular system adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to premedication | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Aseptic meningitis caused by drug | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-related myocardial necrosis syndrome | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Photosensitivity caused by drug (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Polyneuropathy caused by drug (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Allergic drug reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
glaucome dû à un médicament | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Tetrabenazine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Griseofulvin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Amphotericin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Natamycin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Nystatin adverse reaction (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Eruption caused by drug (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Transfusion reaction caused by toxic effect of anticoagulant (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Steroidal ecchymosis (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
ACE inhibitor-aggravated angioedema | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-induced mucositis (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Assessment of adverse drug reactions | Has focus | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | 1 |
Adverse drug reaction prevention (procedure) | Has focus | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | 1 |
Medication side effect education (procedure) | Has focus | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by primarily systemic agents | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to antihistamines | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to capillary-active drug | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to purine derivative diuretic | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to enzymes | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by eye drug | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to keratolytics, keratoplastics and other hair treatment drugs and preparations | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to other drugs and medicines | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to other drug or medicine NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to drug or medicinal substance NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to drug NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse drug event resulting from treatment of disorder | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Localized adverse reaction caused by administration of drug | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antiallergenic drug adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
effet indésirable provoqué par une substance médicinale appropriée correctement administrée | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by drugs primarily acting on the smooth or skeletal muscles or respiratory system | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by analgesics, antipyretics and antirheumatics | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Malignant hypothermia caused by anesthesia | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Pesticide adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-induced asthma | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by drug acting on bone metabolism | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to drug primarily acting on nutrition | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
[X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Immunostimulant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antineoplastic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Immunosuppressant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Alcohol metabolism modifier adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Oral dermatological agent adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Non-ionic surfactant adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Prostaglandin adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Terpenes adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Homoeopathic medicine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anthroposophical medicine adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Herbal medicine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Fixed oil adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Lubricant adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Viscosity modifier adverse reaction (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sulfonamide adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Oral hypoglycemic adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Combined oral contraceptive adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Ergoline drug adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Calcium regulating agent adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Iodine adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Vitamin products adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Potassium adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Zinc adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Fluoride adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Medicinal enzyme adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Topical agent adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Pharmaceutical fluid or solution adverse reaction (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Allergic reaction to drug | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by acidifying agent | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by alkalizing agents | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to pyrazole derivative | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by bromide | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to oxytocic agents | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to antineoplastic and immunosuppressive drugs NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to bromine compounds NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some |
This concept is not in any reference sets